Scientific Advisors

Scientific Advisory Board

FRAXA is indebted to these prominent investigators who volunteer their time to help us devise strategy for advancing research and provide expert opinion on research proposals.

Many of our advisers are actively conducting research on Fragile X at universities or pharmaceutical companies.

Among FRAXA’s Scientific Advisors are winners of the Nobel Prize in Medicine and the Lasker Prize.

Mark Bear 2018

Mark Bear, PhD

Massachusetts Inst. of Technology (MIT)

Elizabeth Berry-Kravis, MD, PhD, Fragile X researcher

Elizabeth Berry-Kravis, MD, PhD

Rush University Medical Center

Bilbe-Graeme

Graeme Bilbe, PhD

Drugs for Neglected Diseases initiative

Justin Fallon, PhD, Brown University, FRAXA research grant

Justin Fallon, PhD

Brown University

Joe Horrigan

Joseph P. Horrigan, MD

AMO Pharma

Steve Hyman

Steven Hyman, MD

Harvard University

Eric Kandel

Eric Kandel, MD

Nobel Laureate, Columbia University

David Nelson

David Nelson, PhD

Baylor College of Medicine

Shikha Sharma

Shikha Sharma, PhD

California Life Sciences

snape-Michael

Michael Snape, PhD

AMO Pharma

Steward-Oswald

Oswald Steward, PhD

University of California, Irvine

Susumu Tonegawa, PhD, at MIT

Susumu Tonegawa, PhD

Nobel Laureate, Massachusetts Inst. of Technology (MIT)

Robert Wong, PhD

Robert Wong, PhD

State University of New York (SUNY) Downstate

Yin-Jerry

Jerry Yin, PhD

University of Wisconsin